Somatic Genitourinary Cancer Taskforce

The Genitourinary Cancer Taskforce will embark on variant curation for FGFR and PARP inhibitor pathways, using Clinical Interpretations of Variants in Cancer (CIViC) platform for variant curation.  The somatic variants should be examined and curated for the clinical significance/clinical management of patients, i.e. their role in the diagnosis, prognosis, therapeutic outcomes, prevention of the disease, or disease surveillance.

Somatic Cancer Subgroup
Membership

The GU taskforce is currently accepting members to join the team and support its variant curation and interpretation activities.

Chairs

Coordinators
Please contact a coordinator if you have questions.

Working Group Membership

Membership spans many fields, including genetics, medical, academia, and industry.